| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |